0 Комментарии
0 Поделились
51 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
HER2 Positive Breast Cancer Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period For structuring the finest market...0 Комментарии 0 Поделились 43 Просмотры 0 предпросмотр
-
HER2 Positive Breast Cancer Treatment Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period The HER2 Positive Breast Cancer...0 Комментарии 0 Поделились 11 Просмотры 0 предпросмотр
-
mTOR Inhibitor Oncology Drug Market Advances with Targeted Cancer Therapy Innovations"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Analysis Report CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period mTOR Inhibitor Oncology Drug Market report objective analysis is...0 Комментарии 0 Поделились 152 Просмотры 0 предпросмотр
-
Small Molecule Targeted Cancer Therapy Market Size, Share & Forecast 2032: Growth Trends and OpportunitiesSmall Molecule Targeted Cancer Therapy Market According to the latest report published by Data Bridge Market Research, the Small Molecule Targeted Cancer Therapy Market Data Bridge Market Research analyses that the global small molecule targeted cancer therapy market which was USD 75,960.00 Million in 2022, would rocket up to USD 124,772.24 Million by 2030 and is expected...0 Комментарии 0 Поделились 33 Просмотры 0 предпросмотр
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Комментарии 0 Поделились 125 Просмотры 0 предпросмотр
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Комментарии 0 Поделились 178 Просмотры 0 предпросмотр
-
How Are Targeted Therapies Shaping the Chordoma Treatment Market?Executive Summary Chordoma Treatment Market: Share, Size & Strategic Insights CAGR Value The global chordoma treatment market size was valued at USD 3.98 billion in 2024 and is expected to reach USD 6.64 billion by 2032, at a CAGR of 6.60% during the forecast period The key topics that have been described in this Chordoma Treatment Market report include market definition, market...0 Комментарии 0 Поделились 214 Просмотры 0 предпросмотр
-
Navigating the Future of Adult Malignant Glioma Therapeutics: Market Growth, Opportunities, and Strategic Insights 2031The Adult Malignant Glioma Therapeutics Market is advancing at a robust pace, propelled by the rising prevalence of malignant brain tumors and the continuous evolution of treatment modalities. According to insights from The Insight Partners, the The Adult Malignant Glioma Therapeutics Market size is expected to reach US$ 5.39 Billion by 2031. The market is anticipated to register a CAGR of 9.8%...0 Комментарии 0 Поделились 189 Просмотры 0 предпросмотр
-
Neurofibromatosis Drugs Market Industry Insights and ForecastNeurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...0 Комментарии 0 Поделились 58 Просмотры 0 предпросмотр
-
Ovarian Cancer Diagnostics and Therapeutics Market Revenue Growth TrendsThe global ovarian cancer diagnostics and therapeutics market is witnessing significant growth due to the increasing prevalence of ovarian cancer, rising awareness regarding early detection, and continuous advancements in precision medicine. Healthcare providers and pharmaceutical companies are investing heavily in innovative diagnostic technologies and targeted treatment approaches to improve...0 Комментарии 0 Поделились 56 Просмотры 0 предпросмотр
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Комментарии 0 Поделились 133 Просмотры 0 предпросмотр
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek